<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PEPG
PepGen
$
()


  • PepGen receives Orphan Drug, Rare Pediatric Disease designations for PGN-EDO51

    3/13/2024 - 07:22am
  • PepGen treatment of Duchenne Muscular Dystrophy gets FDA orphan designation

    3/7/2024 - 18:17pm
  • PepGen price target lowered by $1 at Wedbush, here's why

    3/7/2024 - 08:17am
  • PepGen announces clearance of CTA by U.K. MHRA to begin CONNECT2-EDO51

    3/4/2024 - 07:04am
  • PepGen receives U.S. Fast Track designation for PGN-EDODM1

    2/20/2024 - 08:05am
  • PepGen prices 7.53M shares at $10.635 in underwritten public offering

    2/7/2024 - 07:34am
  • PepGen Inc trading resumes

    1/30/2024 - 10:59am
  • PepGen Inc trading halted, volatility trading pause

    1/30/2024 - 10:49am
  • PepGen appoints DeLena as General Counsel, Secretary

    1/17/2024 - 07:03am
  • PepGen announces first patient dosed in CONNECT1-EDO51 Phase 2 trial

    1/8/2024 - 07:41am
  • PepGen doses first patient in Phase 1 FREEDOM-DM1 trial

    12/18/2023 - 08:04am
  • PepGen announces appointment of Mayer to board of directors

    11/15/2023 - 08:10am
  • PepGen reports Q3 EPS (98c), consensus (88c)

    11/8/2023 - 08:02am
  • PepGen announces FDA lifted clinical hold on its IND for FREEDOM-DM1

    10/12/2023 - 07:06am
  • PepGen announces presentations of data on EDO platform

    9/6/2023 - 08:08am
dynamic_feed Breaking News